Ferreira Sávio Valadares, Sugai Murilo Henrique, Nascimento Guilherme Corrêa, Souza Antonino Caetano, Cabrini Gustavo Colombo, Rodrigues Fernando Martins, D'Avila Cleverson Luiz Rocha, Souza Geovanne Furtado, Zerati Ricardo Vieira, Zerati Miguel
Instituto de Urologia e Nefrologia, São José do Rio Preto, SP, Brasil.
Hospital Padre Albino, Catanduva, SP, Brasil.
Int Braz J Urol. 2025 May-Jun;51(3). doi: 10.1590/S1677-5538.IBJU.2024.0494.
Telesurgery allows the procedures to be carried out over long distances, however due to lack of data, its feasibility has not been consolidated yet. Since it is a promising modality, it is important to illustrate the current scenario on this subject.
To review the literature aiming at the surgical success rate as a primary objective, and secondly, the most important patient outcomes and the network system.
In June 2024, we followed PRISMA guidelines to research trials on urological robotic surgery in humans. We used as exclusion criteria: editorials, specialist's opinions, tele-mentoring, tele-training, small procedures, non-remote surgeries, absence of interest outcomes, telesurgeries in non-humans or in cadaver.
Five hundred and ninety eight studies were identified with peer review and a third reviewer for divergencies, both directed by previously established inclusion and exclusion criteria, selecting 6 studies after the exclusions. We found 54 patients who underwent urological telesurgeries; all of them were accomplished with no complications or need for conversion to open surgery. Almost all the procedures were carried out in China (98.14%) and the most used robotic model was MicroHand S (83.33%). Nephrectomy was the procedure of choice (57%). Mean surgical time was 66.2 (IQR) 56.6 minutes. Intraoperative bleeding time was 68.6 ± 76.7 milliliters. Hospital stay was 5.5 (IQR) 5 days. The distance between main surgeon and the patient was between 2,581.5 (IQR) 2,871 kilometers. 5G network was used the most (98.14%). The total network latency time was 176 (IQR) 10.9 milliseconds.
Despite its limitations, there was evidence demonstrating that robotic surgery in the genitourinary system is safe and feasible, however it is a subject that must be well discussed, and further studies must be carried out.
远程手术可使手术在远距离进行,然而由于缺乏数据,其可行性尚未得到确证。鉴于这是一种有前景的手术方式,阐明该领域的当前情况很重要。
以手术成功率为首要目标,其次以最重要的患者预后及网络系统为目标对文献进行综述。
2024年6月,我们遵循PRISMA指南对人类泌尿外科机器人手术的试验进行研究。我们将以下内容用作排除标准:社论、专家意见、远程指导、远程培训、小型手术、非远程手术、缺乏感兴趣的结果、非人类或尸体的远程手术。
通过同行评审确定了598项研究,并由第三位评审员处理分歧,两者均遵循先前制定的纳入和排除标准,排除后选择了6项研究。我们发现54例患者接受了泌尿外科远程手术;所有手术均顺利完成,无并发症,也无需转为开放手术。几乎所有手术都在中国进行(98.14%),最常用的机器人模型是微手S(83.33%)。肾切除术是首选手术(57%)。平均手术时间为66.2(四分位间距)56.6分钟。术中出血时间为68.6±76.7毫升。住院时间为5.5(四分位间距)5天。主刀医生与患者之间的距离在2581.5(四分位间距)2871公里之间。使用5G网络的情况最为普遍(98.14%)。总网络延迟时间为176(四分位间距)10.9毫秒。
尽管存在局限性,但有证据表明泌尿生殖系统的机器人手术是安全可行的,不过这是一个必须充分讨论的课题,且必须开展进一步研究。